CTGO vs NBIX · $262.9M cap vs P/E 45, rev $1.77B
Contango ORE Inc (CTGO) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
Contango ORE Inc (CTGO) is a gold company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
CTGO does not have a complete income-statement cache yet.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
CTGO currently screens at market cap $262.9M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the CTGO and NBIX stock pages for the full models.
Not investment advice.